The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2018 | CAR T-cell therapy: a new outlook for older patients with aggressive lymphomas?
Raúl Córdoba
• 21 Dec 2018
Raúl Córdoba, MD, PhD, MS, of the Fundación Jiménez Diaz University Hospital, Madrid, Spain, speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA., on the utilization of CAR T-cell therapy as a new approach for elderly patients with lymphomas, including those with aggressive forms of the disease.
